BP
₹2,213.60
+65.10(+3.03%)
BPLPHARMA₹2,213.60+3.03%
Value & Investment Index
VIIVII Detail
90 days · zone the stock traded inMultiples vs Peers
Quality Scores
Versus Its Own History
P/E · P/B percentile bandsScenario analysis
stated assumptions, shown workingsBPLPHARMA valuation summary
Bharat Parenterals Ltd trades at 123.0 times trailing earnings. Return on equity is 4.0% and return on capital employed is 5.8%. The dividend yield is 0.06%. That P/E equals an earnings yield of 0.8%. The median P/E across 102 listed Drug Manufacturers - Specialty & Generic companies is 35.6, so Bharat Parenterals Ltd trades at a 4041% premium to that median.
| P/E | 123.0 |
|---|---|
| ROE | 4.0% |
| ROCE | 5.8% |
| Dividend yield | 0.06% |